Top Revenue Growth Imperatives for Life Sciences Companies

By: Arshad Carim Life Sciences, Revenue Growth Strategy

The game has changed. Today’s life sciences and analytical instruments companies find themselves in a “seller-beware” world of super-informed, highly connected and data-driven buyers. As the industry changes, commercial leaders wonder if their go-to-customer strategies are evolving fast enough to keep up.

Alexander Group’s (AGI) ongoing research looks at trends and key commercial strategies for managing these new types of buyers. Recently, AGI concluded its 2019 Life Sciences & Analytical Instruments Sales Pulse Survey. Twenty+ commercial leaders offered their perspectives on the latest trends and top growth imperatives. Based on the findings from these executive interviews, AGI prioritized the top revenue growth imperatives for 2019: sales productivity, penetrating high-growth markets, digital strategy and workflow/solution selling.

  • Emphasize Sales Productivity: Established products and low-value customers will be migrated to efficient, scalable low-cost routes to market to enable investment in growth markets
  • Penetrate High-Growth Markets: Differentiated growth will be delivered by targeting emerging sub-segments (e.g., cell therapy, genetic testing, food and beverage, high-growth biomarkers, oncology and others)
  • Go Digital: Transformation efforts will continue to ramp with investments in contemporary customer engagement models and next generation sales enablement
  • Shift To Workflow (Solution) Selling: Marketing and Sales teams will emphasize solutions and target workflows that align with product portfolios and company value propositions

To learn more about the prioritized revenue growth imperatives uncovered in our research and hear the Alexander Group’s insights and recommendations, schedule a briefing today.
__________________
RELATED RESOURCES

1. Life Sciences Sales Trends
8 Life Sciences Sales Trends impacting the industry – video series

TAGS: , , , , ,

Arshad Carim

Arshad Carim is a principal in the San Francisco office, with over 24 years of business and consulting experience. Arshad leads the firm’s health care efforts in the Western region. He also leads consulting engagements and teams, manages key account relationships, drives business development activities and supports talent development. With experience across multiple industries including life sciences, medical device, high technology, and general B2B, Arshad leverages his cross-industry depth to create and implement high-impact solutions.


Prior to joining the Alexander Group, Arshad spent six years gaining experience in various marketing and sales management positions in the telecommunications industry. Arshad has directly managed a large regional wireless company’s local market sales force, providing leadership to a team of sales representatives. He managed major nationwide product launches and developed marketing plans for new feature releases. Arshad holds an MBA from the University of California, Berkeley Haas School of Business, a B.S. in marketing/management from the University of Pennsylvania Wharton School of Business, and a B.A.Sc. from the University of Pennsylvania School of Engineering and Applied Science.


HAVE A QUESTION ABOUT THIS POST OR WANT TO REACH OUT TO THE AUTHOR?  CONTACT US »